M&A Deal Summary

Supernus Pharmaceuticals Acquires US WorldMeds - CNS Portfolio

On June 9, 2020, Supernus Pharmaceuticals acquired life science company US WorldMeds - CNS Portfolio from US WorldMeds

Acquisition Highlights
  • This is Supernus Pharmaceuticals’ 2nd transaction in the Life Science sector.
  • This is Supernus Pharmaceuticals’ 2nd transaction in the United States.
  • This is Supernus Pharmaceuticals’ 1st transaction in Kentucky.

M&A Deal Summary
Date 2020-06-09
Target US WorldMeds - CNS Portfolio
Sector Life Science
Buyer(s) Supernus Pharmaceuticals
Sellers(s) US WorldMeds
Deal Type Divestiture

Target

US WorldMeds - CNS Portfolio

Kentucky, United States
US WorldMeds LLC - CNS Portfolio (central nervous system) is involved in developing and commercializing products for the treatment of Parkinson’s disease.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Supernus Pharmaceuticals

Rockville, Maryland, United States
Category Company
Founded 2005
Sector Life Science
Employees652
Revenue 608M USD (2023)
DESCRIPTION

Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) disorders. Supernus Pharmaceuticals was founded in 2005 and is based in Rockville, Maryland.

DEAL STATS #
Overall 2 of 3
Sector (Life Science) 2 of 3
Type (Divestiture) 1 of 1
State (Kentucky) 1 of 1
Country (United States) 2 of 3
Year (2020) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-09-13 Biscayne Neurotherapeutics

Miami, Florida, United States

Biscayne Neurotherapeutics is a developer of a novel treatment for epilepsy. Biscayne Neurotherapeutics is based in Miami, Florida.

Buy $15M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-10-11 Adamas

Emeryville, California, United States

Adamas is a specialty pharmaceutical company driven to improve the lives of those affected by chronic disorders of the central nervous system (CNS). Its achieve this by modifying the pharmacokinetic profiles of approved drugs to create novel therapeutics for use alone and in fixed-dose combination products. Adamas was founded in 2000 and is based in Emeryville, California.

Buy $450M

Seller(S) 1

SELLER

US WorldMeds

Louisville, Kentucky, United States
Category Company
Founded 2001
Sector Life Science
DESCRIPTION

US WorldMeds is a Kentucky-based specialty pharmaceutical company that develops, licenses and commercializes unique medical therapies that address unmet patient needs. US WorldMeds’ products include novel treatments for malignant hyperthermia, cervical dystonia and symptoms of opiate withdrawal.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (Kentucky) 1 of 1
Country (United States) 1 of 1
Year (2020) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-08-13 Solstice Neurosciences

Malvern, Pennsylvania, United States

Solstice Neurosciences is a specialty biopharmaceutical company headquartered in Malvern, PA with a production and manufacturing facility in San Francisco.

Buy $36M
Mergr

Product

Company

Legal